Anti-tumour necrosis factor therapy in Crohn's disease: where are we now?

被引：12
|
作者：
van Deventer, SJH [1 ]
机构：
[1] Acad Med Ctr, Dept Expt Med, NL-1105 AZ Amsterdam, Netherlands
来源：
GUT | 2002年 / 51卷 / 03期
关键词：
D O I：
10.1136/gut.51.3.362
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：362 / 363
页数：2
相关论文
共 50 条
  • [41] Problems encountered during anti-tumour necrosis factor therapy
    Desai, Sheetal B.
    Furst, Daniel E.
    [J]. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2006, 20 (04): : 757 - 790
  • [42] The safety of anti-tumour necrosis factor therapy in rheumatoid arthritis
    Askling, Johan
    Dixon, Will
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2008, 20 (02) : 138 - 144
  • [43] Anti-tumour necrosis factor (TNF)-α therapy in undifferentiated spondyloarthropathy
    Schnarr, S
    Kuipers, JG
    Zeidler, H
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2002, 20 (06) : S126 - S129
  • [44] Granuloma annulare induced by anti-tumour necrosis factor therapy
    Voulgari, P. V.
    Markatseli, T. E.
    Exarchou, S. A.
    Zioga, A.
    Drosos, A. A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (04) : 567 - 570
  • [45] Demyelination during anti-tumour necrosis factor therapy for psoriasis
    Boggs, J. M. E.
    Barnes, L.
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2018, 43 (05) : 577 - 578
  • [46] Retention on anti-tumour necrosis factor therapy: the Waikato experience
    Ip, Ken
    Hartley, Lorraine
    Solanki, Kamal
    White, Douglas
    [J]. NEW ZEALAND MEDICAL JOURNAL, 2015, 128 (1415) : 34 - 40
  • [47] Anti-tumour necrosis factor therapy associated with cutaneous vasculitis
    Livermore, PA
    Murray, KJ
    [J]. RHEUMATOLOGY, 2002, 41 (12) : 1450 - 1452
  • [48] Anti-Tumour Necrosis Factor Therapy for Ulcerative ColitisEvidence to Date
    Chandrashekhar Thukral
    Adam Cheifetz
    Mark A. Peppercorn
    [J]. Drugs, 2006, 66 : 2059 - 2065
  • [49] Does weight-adjusted anti-tumour necrosis factor treatment favour obese patients with Crohn's disease?
    Bhalme, Mahesh
    Sharma, Abhishek
    Keld, Richard
    Willert, Robert
    Campbell, Simon
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 25 (05) : 543 - 549
  • [50] Ustekinumab Versus Anti-tumour Necrosis Factor Alpha Agents as Second-Line Biologics in Crohn's Disease
    Eriksson, Carl
    Soderling, Jonas
    Karlqvist, Sara
    Broms, Gabriella
    Everhov, Asa H.
    Bergemalm, Daniel F.
    Ludvigsson, Jonas
    Olen, Ola
    Halfvarson, Jonas
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2023, 68 (07) : 3119 - 3128
12345